Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets
The aim of this research was to develop a new hydrophilic matrix system containing norfloxacin (NFX). Extended-release tablets are usually intended for once-a-day administration with benefits to the patient and lower discontinuation of the therapy. Formulations were developed with hydroxypropylmethy...
Main Authors: | Paulo Renato Oliveira, Cassiana Mendes, Lilian Klein, Maximiliano da Silva Sangoi, Larissa Sakis Bernardi, Marcos Antônio Segatto Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/716736 |
Similar Items
-
Monolithic LC method applied to fesoterodine fumarate low dose extended-release tablets: Dissolution and release kinetics
by: Maximiliano S. Sangoi, et al.
Published: (2015-04-01) -
Factors Affecting the Formulation of Carbamazepine Extended Release Tablet
by: Samer H. Aziz, et al.
Published: (2017-03-01) -
Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose
by: Sachiko Fukui, et al.
Published: (2017-03-01) -
Formulation and Evaluation of Sustained Release Matrix Tablets of Aceclofenac
by: Priyanka Singh, et al.
Published: (2021-05-01) -
Formulation, evaluation and optimization of sustained release matrix tablets of captopril
by: V Pinank Pandya, et al.
Published: (2012-01-01)